Company: INTS
Filing Date: 2025-05-13
Form Type: 10-Q
Source: 0001567264-25-000039
Chunk: 23

Company: INTENSITY THERAPEUTICS, INC.
Filing Date: 2025-05-13
Form: 10-Q
Item: Part I, Item 1
Chunk 23
---
 As of March 31, 2025, 2,455,011 shares were available for issuance under the 2021 Plan.

8

The Company recorded total stock-based compensation for its outstanding stock options and warrants in its Statements of Operations as follows (in thousands):Three Months Ended March 31,20252024Research and development$160 $566 General and administrative275 589 Total stock-based compensation expense$435 $1,155 Stock optionsThe following table summarizes the range of assumptions used to estimate the fair value of stock options issued using the Black-Scholes-Merton option pricing model:Three Months Ended March 31,20252024Stock pricen/a$5.19Exercise pricen/a$5.19Expected volatilityn/a97.06%Risk free interest ratesn/a4.12%Expected term (years)n/a5 to 6.25The Company did not issue stock options for the three months ended March 31, 2025. For the three months ended March 31, 2024, a dividend yield of 0% was used because the Company has not historically paid and does not intend to pay a dividend on common stock in the foreseeable future. The expected stock price volatility assumption was estimated based on the historical volatilities for industry peers, as the Company had no active market for its stock prior to the IPO and limited history for issuance price of its stock. The risk-free rate assumption is determined using the yield currently available on U.S. Treasury zero coupon issues with a remaining term commensurate with the expected term of the award. The expected term of the option represents the period the options are expected to be outstanding.The following table summarizes the activity for stock options for the three months ended March 31, 2025:OptionsWeighted-Average Exercise PriceWeighted Average Remaining Contractual Term (in years)Aggregate Intrinsic Value (in thousands)Outstanding at December 31, 20242,587,129 $6.14 7.9$— Issued— $— Exercised— $— Forfeited and cancelled(44,062)$3.55 Outstanding at March 31, 20252,543,067 $6.18 7.6$— Exercisable at March 31, 20251,435,229 $7.40 6.4$— All options expire 10 years from date of grant. Options outstanding